Concepedia

Javier Sabater

JS

Statistics

Publications

7

Citations

2.3K

H-Index

7

Active since

2014

Affiliations

Bristol-Myers Squibb (United States)(Current)

Dana-Farber Cancer Institute

Melanoma Institute Australia

University of Colorado Denver

Memorial Sloan Kettering Cancer Center

Javier Sabater is an author at Bristol-Myers Squibb (United States) specializing in oncology, radiation oncology, and health studies.

ORCID

Top concepts

Publications per year

2014–2020

7

Publications

7

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

Jeffrey S. Weber, Mario Mandalà, Michele Del Vecchio et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text

Health-related quality of life results from the phase III CheckMate 067 study

Dirk Schadendorf, James Larkin, Jedd D. Wolchok et al. · European Journal of Cancer · 2017 · 94 citations · Full text

, , +7

Sequential Treatment Approaches in  the Management of <i>BRAF</i> Wild-Type Advanced Melanoma: A Cost–Effectiveness Analysis

Ahmad A. Tarhini, Ágnes Benedict, David F. McDermott et al. · Immunotherapy · 2018 · 26 citations · Full text

The Economic Burden of Posttransplant Events in Renal Transplant Recipients in Europe

G. Chamberlain, Keshwar Baboolal, Hayley Bennett et al. · Transplantation · 2014 · 22 citations

Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England

Dawn Lee, A. Amadi, Javier Sabater et al. · PharmacoEconomics - Open · 2018 · 20 citations · Full text

1–5 of 7